Literature DB >> 10579560

Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.

W Sihver1, P G Gillberg, A L Svensson, A Nordberg.   

Abstract

The laminar binding distribution of three nicotinic receptor agonists, [3H](-)nicotine, [3H]cytisine, and [3H]epibatidine, and their relation to the [3H]vesamicol binding, which is known to represent the vesicular acetylcholine transport sites, was performed employing in vitro autoradiography on the medial temporal cortex (Brodmann area 21). Autopsied brain tissue from nine Alzheimer patients and seven age-matched controls were used. The binding pattern of the three nicotinic ligands in the normal cortex was in general similar, showing binding maxima in the cortical layers I, III and V. The binding of [3H](-)nicotine, [3H]cytisine, and [3H]epibatidine was lower in the older controls and more uniform throughout the layers as compared with younger controls. There was a significant age-related decrease in the binding of the three nicotinic ligands within the controls (age range: 58 to 89 years; P[3H](-)nicotine = 0.002, P[3H]epibatidine = 0.010, P[3H]cytisine = 0.037). In the older controls, the [3H]epibatidine binding was much decreased as compared with that of [3H](-)nicotine and [3H]cytisine. This may indicate a higher selectivity of [3H]epibatidine for a nicotinic receptor subtype that is particularly affected by aging. The laminar binding pattern of [3H]vesamicol showed one maximum in the outer cortical layers II/III. The [3H]vesamicol binding did not change with aging. The binding of all ligands was significantly decreased in all layers of the temporal cortex in Alzheimer's disease, but the [3H]vesamicol binding decreased only half as much as the nicotinic receptors. Also, choline acetyltransferase activity was percentually more reduced than [3H]vesamicol binding in Alzheimer's disease. The cortical laminar binding pattern of all 3H-ligands was largely absent in the Alzheimer's disease cases. The less severe loss of vesicular acetylcholine transport sites as compared with the loss of the nicotinic receptors and choline acetyltransferase activity may suggest that vesamicol binding sites might be more preserved in presynaptic terminals still existing and thereby expressing compensatory capacity to maintain cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579560     DOI: 10.1016/s0306-4522(99)00295-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.

Authors:  J T O'Brien; S J Colloby; S Pakrasi; E K Perry; S L Pimlott; D J Wyper; I G McKeith; E D Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

Review 2.  In vitro imaging techniques in neurodegenerative diseases.

Authors:  Bengt Långström; Per E Andrén; Orjan Lindhe; Marie Svedberg; Håkan Hall
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

3.  Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.

Authors:  Caterina M Hernandez; Helga Høifødt; Alvin V Terry
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

4.  Measuring α4β2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate.

Authors:  Ansel T Hillmer; Dustin W Wooten; Maxim S Slesarev; Elizabeth O Ahlers; Todd E Barnhart; Mary L Schneider; Jogeshwar Mukherjee; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-14       Impact factor: 6.200

Review 5.  Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex.

Authors:  Eliane Proulx; Matthew Piva; Michael K Tian; Craig D C Bailey; Evelyn K Lambe
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

6.  Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer's disease dementia.

Authors:  David L Sultzer; Aaron C Lim; Hailey L Gordon; Brandon C Yarns; Rebecca J Melrose
Journal:  Alzheimers Res Ther       Date:  2022-02-07       Impact factor: 8.823

Review 7.  Current radiotracers to image neurodegenerative diseases.

Authors:  Solveig Tiepolt; Marianne Patt; Gayane Aghakhanyan; Philipp M Meyer; Swen Hesse; Henryk Barthel; Osama Sabri
Journal:  EJNMMI Radiopharm Chem       Date:  2019-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.